GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gland Pharma GLAND.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

3,302.40

+4.20%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹64.31bn

FY2017FY2026

Net income

₹10.27bn

FY2017FY2026

Free cash flow

₹7.41bn

FY2017FY2026

Shareholders' equity

₹103.58bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹64.31bn₹56.17bn₹56.65bn₹36.25bn₹44.01bn₹34.63bn₹26.33bn₹20.44bn₹16.20bn₹14.79bn
Research and development₹2.23bn₹1.92bn₹1.95bn₹2.01bn₹2.27bn₹1.22bn₹922.0m₹880.2m₹571.0m₹507.6m
Operating income₹12.39bn₹17.38bn₹18.23bn₹11.57bn₹15.89bn₹14.19bn₹10.46bn₹7.59bn₹6.34bn₹6.85bn
Net income₹10.27bn₹6.99bn₹7.72bn₹7.81bn₹12.12bn₹9.97bn₹7.73bn₹4.52bn₹3.21bn₹4.14bn
Diluted earnings per share62.3042.4046.8747.4373.5560.6948.5429.1819.4725.09

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹125.11bn₹112.25bn₹106.61bn₹87.78bn₹78.34bn₹64.96bn₹40.86bn₹35.24bn₹29.29bn₹24.74bn
Cash and short-term investments₹34.33bn₹29.52bn₹19.39bn₹37.63bn₹32.43bn₹30.03bn₹13.12bn₹7.21bn₹6.51bn₹5.33bn
Total liabilities₹21.53bn₹20.74bn₹19.37bn₹8.19bn₹6.76bn₹5.93bn₹4.40bn₹6.62bn₹5.19bn₹3.84bn
Debt₹2.84bn₹3.14bn₹3.72bn₹44.5m₹47.4m₹50.0m₹60.1m₹66.3m₹71.4m₹63.8m
Shareholders' equity₹103.58bn₹91.51bn₹87.24bn₹79.59bn₹71.58bn₹59.03bn₹36.46bn₹28.62bn₹24.10bn₹20.90bn
Shares outstanding165m165m165m165m165m164m159m155m165m165m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹12.31bn₹9.15bn₹9.97bn₹3.64bn₹7.91bn₹6.05bn₹7.01bn₹1.85bn₹2.02bn₹4.76bn
Capital spending−₹4.91bn−₹3.85bn−₹3.90bn−₹2.23bn−₹5.22bn−₹2.29bn−₹1.95bn−₹1.36bn−₹851.8m−₹1.16bn
Free cash flow₹7.41bn₹5.30bn₹6.07bn₹1.41bn₹2.69bn₹3.76bn₹5.06bn₹495.1m₹1.17bn₹3.60bn
Dividends paid−₹2.97bn−₹3.29bn————————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹18.00bn₹17.43bn₹16.95bn₹14.87bn₹15.06bn₹14.25bn₹13.84bn₹14.06bn
Operating income₹3.78bn₹4.04bn₹3.27bn₹2.08bn₹2.67bn₹1.81bn₹4.80bn₹4.06bn
Net income₹3.17bn₹3.67bn₹2.61bn₹1.84bn₹2.15bn₹1.87bn₹2.05bn₹1.64bn
Diluted earnings per share19.2222.2315.8711.1513.0811.3212.429.92
Cash from operations———₹5.93bn————
Capital spending———−₹1.94bn————
Free cash flow———₹3.99bn————
Total assets—₹125.11bn—₹118.00bn—₹112.25bn—₹108.67bn
Cash and short-term investments₹33.59bn₹34.33bn₹32.02bn₹27.04bn₹29.52bn₹30.50bn₹28.20bn₹28.20bn
Debt—₹2.60bn—₹1.98bn—₹2.84bn—₹2.95bn
Shareholders' equity₹103.58bn₹103.58bn₹95.63bn₹95.63bn₹91.51bn₹91.51bn₹87.88bn₹87.88bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue21.1%13.2%—
Operating income2.3%-2.7%—
Net income9.6%0.6%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings50.740.638.040.621.463.448.2
Price to sales8.15.05.28.75.918.314.1

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 14 Aug 2025.

FY2026FY2025
Paid in the year18.0020.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.